Andrew J. Cutler, MD

New phase 3 data highlights seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting primary end points. Andrew J. Cutler, MD, shares his thoughts.

Andrew Cutler, MD, shares his key takeaway advice to psychiatrists for the diagnosis and treatment of patients with bipolar 1 disorder.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, share their insights into considerations surrounding the use of long-acting injectables in bipolar 1 disorder.

Experts in psychiatry comment on the challenges of patient adherence to bipolar 1 disorder treatments and discuss the efficacy and safety of LAIs.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, highlight the use of long-acting injectables (LAIs) as a treatment option for bipolar 1 disorder.

Experts in psychiatry discuss the use of antipsychotics for treatment of bipolar 1 disorder.

Andrew Cutler, MD, reviews the different types of medications for the management of bipolar I disorder.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, review FDA approved medications for the treatment of bipolar I disorder.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss implications of pharmacogenetic testing in ADHD.

Experts in psychiatry discuss common comorbidities associated with bipolar I disorder, highlighting substance use disorders and anxiety.

Drs Vladimir Maletic and Andrew Cutler explore symptoms associated with bipolar I disorder, such as sensory acuity, recurrent depression, and manic episodes.

ADHD experts discuss factors that drive treatment selection when selecting therapy for an adult with ADHD.

Theresa Cerulli, MD, and Andrew J. Cutler, MD, provide insight on goals of therapy for patients with ADHD.

Stephen Faraone, PhD, presents the case of a 24-year-old patient with ADHD.

Vladimir Maletic, MD, MS, and Andrew Cutler, MD, comment on the value of studying genetics and family history for diagnosing and treating bipolar 1 disorder.

Drs Vladimir Maletic and Andrew Cutler provide an overview of symptom differences between bipolar 1 disorder (B1D) and bipolar 2 disorder (B2D).

ADHD experts discuss the importance of an integrative approach in the treatment of adults with ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss addressing non-adherence and the stigma of ADHD.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.

Experts in psychiatry provide insight on a patient case as well as discuss challenges with ADHD.

Stephen Faraone, PhD, presents the case of a 23-year-old patient with ADHD.

A panel of ADHD specialists discuss the impact of treatment delay when dealing with an adult patient.

Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to co-manage a patient with ADHD with other specialties.

Experts in psychiatry discuss tips to differentiate between ADHD and other co-morbid psychiatric disorders.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss factors which prompt adults for an ADHD consultation.

Stephen Faraone, PhD, presents the case of a 19-year-old male with ADHD.

Experts in psychiatry discuss the future of ADHD management as well as challenges when approaching treatment of adult ADHD.

Stephen Faraone, PhD; Theresa Cerulli, MD; Craig Chepke, MD, FAPA; and Andrew J. Cutler, MD, discuss efficacy and safety of treatment options in adults with ADHD.

Craig Chepke, MD, FAPA, and Andrew J. Cutler, MD, discuss unmet needs in adults with ADHD.